


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.18%
-3.67%
+4.15%
-1.08%
MRNA
Moderna
$57.80
Strengths

Earnings are forecast to grow

Investors confidence is positive

Trading below its fair value
MRNA Price Performance
$40.87 (+41.42%)
$27.97 (+106.65%)
$27.53 (+109.95%)
$32.45 (+78.12%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue declined YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
MRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MRNA Street Sentiment is bullish and have positive views on the near-term outlook
MRNA has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Jan 06, 2026
Downgrade
Neutral
UBS
Nov 22, 2025
Reiterate
Overweight
Piper Sandler
Oct 24, 2025
Reiterate
Buy
UBS
Oct 23, 2025
Reiterate
Neutral
Citigroup
Oct 20, 2025
Reiterate
Hold
Needham
NVAX
Novavax
9.89
+4.21%
VALN
Valneva SE
10.97
+7.02%
BNTX
BioNTech
103.80
+3.02%
AMGN
Amgen
379.27
+0.60%
What is MRNA current stock price?
What are MRNA stock strengths?
What is MRNA Risk Level?
What is MRNA market cap and volume?
What is MRNA current Stock IQ?
Should I buy MRNA stock right now?
Is MRNA a Strong Buy right now?
What does a 'Strong Buy' rating mean for MRNA?
What does a 'Strong Sell' rating mean for MRNA?
What factors influence MRNA's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
MRNA
Moderna
Current Price
$57.80
Runners Also Watch
NVAX
Novavax
9.89
+4.21%
VALN
Valneva SE
10.97
+7.02%
BNTX
BioNTech
103.80
+3.02%
AMGN
Amgen
379.27
+0.60%

MRNA Price Performance
$40.87 (+41.42%)
$27.97 (+106.65%)
$27.53 (+109.95%)
$32.45 (+78.12%)
MRNA Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue declined YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
Trading below its fair value
MRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MRNA Street Sentiment is bullish and have positive views on the near-term outlook
MRNA has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
MRNA Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Investors confidence is positive

Trading below its fair value
MRNA Latest Analysis
The Sun Will Shine On Moderna Again - Initiating With A Buy.
Today
Stock Market Today: Dow Higher Amid Iran Trump Tariff News. Moderna Soars (Live Coverage).
The Dow Jones index slipped Wednesday amid Iran and tariff news. Nvidia stock and Tesla bounced back from recent losses.
The post Stock Market Today: Dow Higher Amid Iran Trump Tariff News. Moderna Soars (Live Coverage) appeared first on Inv
Today
Moderna gains as Arbutus/ Genevant settlement removes major financial risk.
Today
Today
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang.
Today
Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement.
Today
Moderna Wins EU Nod for Covid-Flu Combo Shot Stalled in US. European regulators gave the green light to Moderna Inc.s novel combination flu and Covid shot handing a victory to the embattled vaccine maker as it struggles to get the same shot approved in the US.
Fri Feb 27, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MRNA Stock trends
MRNA Stock performance
MRNA Stock analysis
MRNA investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.